Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Acumen Pharmaceuticals Inc (ABOS)

Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Acumen Pharmaceuticals Inc 427 PARK ST. CHARLOTTESVILLE VA 22902 USA

www.acumenpharm.com Employees: 52 P: 434-297-1000

Description:

Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It involved in developing a novel disease for Alzheimer. The company's product pipeline consist ACU193. Acumen Pharmaceuticals Inc. is based in CHARLOTTESVILLE, Va.

Key Statistics

Overview:

Market Capitalization, $K 138,785
Enterprise Value, $K 101,795
Shares Outstanding, K 60,080
Annual Sales, $ 0 K
Annual Net Income, $ -52,370 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -29,770 K
EBIT, $ -92,910 K
EBITDA, $ -95,850 K
60-Month Beta 0.04
% of Insider Shareholders 7.10%
% of Institutional Shareholders 71.01%
Float, K 55,814
% Float 92.90%
Short Volume Ratio 0.63

Growth:

1-Year Return 0.42%
3-Year Return -71.34%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.50 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -1.38
EPS Growth vs. Prev Qtr -47.06%
EPS Growth vs. Prev Year -108.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ABOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -32.99%
Return-on-Assets % -27.99%
Profit Margin % 0.00%
Debt/Equity 0.14
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.66
Book Value/Share 3.62
Interest Coverage -89.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar